Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Improving walking engagement among school employees in El Paso

Official title: Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

Run by University of Texas, El Paso · NCT06411769 · Data updated 2026-11-12

This study is testing a program to help school employees in El Paso walk more by using challenges and support through text messages to see if it improves their health.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment406 (estimated)
SponsorUniversity of Texas, El Paso
Academic / other
Locations2 sites (El Paso, Texas and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedMarch 16, 2026
Trial IDNCT06411769 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are full-time school district employees aged 18 or older who can walk without limitations and are willing to engage with the walking program.

Probably not a fit

Patients who work at multiple schools or those who have previously participated in similar walking challenges may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention aims to enhance walking engagement among school employees in El Paso, Texas, through the 50,000 for Life (50K4Life) program. The study will implement a two-phased adaptive intervention involving random assignments to either a walking challenge alone or with SMS text messaging support. In the second phase, schools that do not show sufficient engagement will receive tailored interventions, either at the individual level with remote education and coaching or at the school level with group sessions and environmental modifications. The goal is to promote brisk walking and improve health outcomes among predominantly Mexican American school district employees.

Why it matters

Potential benefit: If successful, this intervention could significantly increase physical activity levels and reduce the risk of cardiometabolic diseases among school employees.

How similar studies have gone: While employer-based walking programs have shown promise in other regions, this specific approach has not been widely tested on the U.S.-Mexico border, making it a novel intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A school is eligible if it is located within one of the four target school districts
* adult 18 years or older
* full-time school-based school district employee
* not pregnant and able to walk without physical limitations or assistive device
* willing to wear our Fitbit tracking device or use their own tracking device for 18 months
* own a smartphone
* willingness to use a personal smartphone for tracking activity related to the Fitbit tracker, access online intervention content, and receive text messages.

Exclusion Criteria:

* Works at more than one school
* Does not work on a district school campus
* schools that previously participated in walking challenges

Where it's running

  • University of Texas at El Paso
    El Paso, Texas, United States
    Recruiting
  • University of Texas at El Paso
    El Paso, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Jennifer J Salinas, Ph.D., LMSW — University of Texas, El Paso
  • Study coordinator: Jennifer J Salinas, Ph.D.,LMSW
  • Email: jsalinas7@utep.edu
  • Phone: 915-747-7292

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.